Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

5 Nov 2018 07:00

RNS Number : 2648G
Cenkos Securities PLC
05 November 2018
 

 

 

 5 November 2018

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

The Board is pleased to announce that, subject to FCA approval, Jim Durkin is to be appointed as an Executive Director and to the position of Chief Executive Officer once regulatory approval has been received. In the interim period Anthony Hotson remains as the Company's Chief Executive Officer.

Jim, a founding shareholder of the Company, was formerly Cenkos' Chief Executive Officer in the period December 2011 to July 2017. Jim resigned as Chief Executive Officer in July 2017. Jim Durkin has over 30 years' experience in the UK securities industry. During his career he has had substantial experience originating and executing corporate finance transactions across a range of industries including insurance, property, financials and utilities.

The Board today also announces that Gerry Aherne, the Chairman of the Company has informed the Board that he will step down and retire from the Company with immediate effect.

The Board would like to thank Gerry for his commitment and contribution to the Company as Chairman over the past six years and wish him well in the future.

The Board will commence the search for a new Chairman. Jeff Hewitt a Non-executive Director has been appointed as the acting Chairman in the interim period.

Jeff Hewitt the acting Chairman commented that:

"We welcome Jim back to the Company and have every confidence in Jim in leading the Company going forward. Jim is well placed to undertake the role having previously been on the Board and has been actively involved in the successful management of the Company."

AIM Rules disclosure under Schedule 2(g) of the AIM Rules

James John Durkin (known as Jim Durkin) holds 4,985,831 ordinary shares of 1p each in the Company representing 9.01% of the issued share capital of the Company.

In addition to his appointment to the Board, James John Durkin, aged 58, holds or has held the following directorships or partnerships in the past five years:

Current directorships:

JDPL Limited

 

Previous directorships:

Cenkos Securities plc

Cenkos Nominee UK Limited resigned

Cenkos Fund Management Limited

JDPL 2 Limited

 

There is no further information that is required to be disclosed with regards to the appointment of Jim Durkin pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

For further information, please contact: 

 

Cenkos Securities plc

Jeff Hewitt, Acting Non- Executive Chairman

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABJBBTMBBMMJP
Date   Source Headline
6th Nov 20179:54 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 20179:49 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20179:56 amRNSForm 8.5 (EPT/NON-RI)
30th Oct 201710:52 amRNSHolding(s) in Company
24th Oct 20179:24 amRNSForm 8.5 (EPT/NON-RI)
19th Oct 20177:00 amRNSDirectorate Change
18th Oct 20174:53 pmRNSEBT Share Purchase
16th Oct 20177:00 amRNSBlock Admission Interim Review
13th Oct 20172:09 pmRNSHolding(s) in Company
28th Sep 20174:41 pmRNSDirector/PDMR Shareholding
26th Sep 20177:00 amRNSHalf-year Report
21st Sep 20174:51 pmRNSEBT Share Purchase
19th Sep 20175:36 pmRNSHolding(s) in Company
13th Sep 20174:58 pmRNSDirectorate Change
13th Sep 20172:31 pmRNSHolding(s) in Company
22nd Aug 20176:09 pmRNSEBT Share Purchase
14th Aug 20179:40 amRNSForm 8.5 (EPT/NON-RI)
11th Aug 20179:44 amRNSForm 8.5 (EPT/NON-RI)
9th Aug 201710:39 amRNSForm 8.5 (EPT/NON-RI)
4th Aug 201710:23 amRNSForm 8.5 (EPT/NON-RI)
4th Aug 20177:00 amRNSDirectorate Change
2nd Aug 20174:44 pmRNSHolding(s) in Company
2nd Aug 20177:00 amRNSFurther re Directorate Change
1st Aug 201710:13 amRNSForm 8.5 (EPT/NON-RI)
25th Jul 201710:10 amRNSForm 8.5 (EPT/NON-RI)
24th Jul 201710:09 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20176:20 pmRNSEBT Share Purchase
21st Jul 20179:51 amRNSForm 8.5 (EPT/NON-RI)
18th Jul 201710:00 amEQSCenkos Securities PLC: Small Cap Advisor of the Year award at the fifth annual Nex Exchange Small Cap Awards 2017
17th Jul 201710:37 amRNSForm 8.5 (EPT/NON-RI)
11th Jul 20177:00 amRNSDirector/PDMR Shareholding
7th Jul 20179:44 amRNSForm 8.5 (EPT/NON-RI)
5th Jul 20177:00 amRNSDirectorate Changes
4th Jul 20179:59 amRNSForm 8.5 (EPT/NON-RI)
27th Jun 20179:54 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 201710:28 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20177:57 amRNSStatement re Press Speculation
20th Jun 20179:47 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 20172:56 pmRNSEBT Share Purchase
16th Jun 201710:43 amRNSForm 8.5 (EPT/NON-RI)
14th Jun 201710:09 amRNSForm 8.5 (EPT/NON-RI)
2nd Jun 20174:03 pmRNSDirector/PDMR Shareholding
30th May 20175:48 pmRNSEBT Share Purchase
26th May 20179:23 amRNSForm 8.5 (EPT/NON-RI)
23rd May 20175:48 pmRNSEBT Share Purchase Plan
19th May 201710:38 amRNSForm 8.5 (EPT/NON-RI)
17th May 20174:22 pmRNSDirector/PDMR Shareholding
17th May 20172:01 pmRNSResult of AGM
12th May 201710:31 amRNSForm 8.5 (EPT/NON-RI)
12th May 201710:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.